ML P19 8 mg (Doxazosin 8 mg)
Pill imprint ML P19 8 mg has been identified as Doxazosin mesylate 8 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- ML P19 8 mg
- Strength:
- 8 mg
- Color:
- Green
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dava Pharmaceuticals Inc.
- National Drug Code (NDC):
- 67253-0383
- Inactive Ingredients:
- microcrystalline cellulose
lactose
magnesium stearate
sodium lauryl sulfate
FD&C Blue No. 2
D&C Yellow No. 10
aluminum oxide
More about doxazosin
Consumer resources
- Other brands: Cardura, Cardura XL
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
